Background: The incidence of methicillin-resistant Staphylococcus aureus (MRSA) carriers and infections continues to rise. Some specialties have demonstrated a reduction in infection through appropriate screening and treatment. Objectives: We sought to investigate the incidence of preoperative colonization, postoperative conversion, and whether this had any impact on outcomes in patients undergoing post-mastectomy breast reconstruction (BR). Methods: This is a prospective study of a series of 122 BR patients from a single surgeon from May 2013 to March 2015. Nasal swabs were obtained at preoperative and postoperative clinic visits. The incidence of preoperative and postoperative colonization, demographic, and clinical variables were analyzed and compared to complication rates within 90 days of surgery. Results: The incidence of MRSA colonization was 3.3% (n = 4) preoperatively and 4.1% (n = 5) postoperatively. One patient was positive at both time points, and 4 patients converted postoperatively. Preoperative or postoperative colonization with MRSA was not associated with any specific patient demographics. Hospital length of stay tended to be longer in patients colonized both preoperatively (2.8 days vs 1.6 days, P = .075) and postoperatively (2.8 days vs 1.8 days, P = .072). Postoperative colonization trended toward an increased incidence of any complication (80.0% vs 35.7%, P = .068) and was significantly associated with delayed wound healing (40.0% vs 4.8%, P = .035). Having a minor complication (P = .073) and implant exposure (P = .056) tended to be associated with postoperative carriers. Conclusions: The incidence of MRSA in breast reconstruction patients is relatively low, yet complications rates are higher in those patients. Multicenter randomized trials should be conducted to determine if there is a role for preoperative screening and treatment of MRSA carriers.
poor aesthetic result, and decreased patient satisfaction. [7] [8] [9] [10] Specific to implant-based reconstruction, SSIs may lead to tissue envelope distortion, explantation, and capsular contracture. 7, 8, 11 While many of the risk factors for postoperative infections, such as radiation, are uncontrollable, identification of any manageable risk factor should be undertaken to prevent the long-term sequela of postoperative infections. Staphylococcus skin flora are common organisms cultured from SSIs following breast reconstruction, and recently increased morbidity has been associated with methicillinresistant Staphylococcus aureus (MRSA) infections.
Previously MRSA was only acquired from healthcare institutions, yet community acquired infection and colonization have become increasing prevalent. The Center for Disease Control and Prevention (CDC) reports that .8% to 1.5% of the general public is now colonized by MRSA. 12, 13 In cancer patients the risk for MRSA colonization and infection is even further increased. 14, 15 Importantly, large cohort studies have shown that preoperative nasal MRSA carriage is independently predictive of increased risk for postoperative MRSA wound infections. 12, 16, 17 Though rampant in medical and surgical intensive care units, the prevalence of MRSA carriers in routine surgical patients is also influential on postoperative outcomes. The utilization of screening and treatment programs have been shown to decrease the incidence of MRSA SSIs and postoperative infections. 18 Previous studies of patients undergoing Moh's surgery, have shown that screening and treatment protocols result in an overall decreased incidence of postoperative MRSA infections. 17 The significant morbidity following wound infections in the reconstructive patient necessitates understanding the risk of MRSA nasal carriage in our patient population.
The goal of this study was to obtain baseline analyses in order to determine if there is a higher incidence of MRSA carriers in breast cancer patients. Additionally, we sought to analyze the nasal carriage conversion rate after breast reconstruction and if this impacted complication rates. We hypothesize that there is a higher incidence of MRSA carriers than might be expected and that preoperatively colonized patients are more likely to have increased rates of postoperative infectious complications and as a result more likely to be subject to aforementioned secondary sequelae.
METHODS
This is a prospective study of a consecutive series of breast cancer patients scheduled for elective reconstructive surgery between May 2013 and March 2015 by one primary surgeon (A.L) at a single academic medical center.
Patient Population
Following approval by the Emory University Institutional Review Board, any patient electively scheduled for all methods of BR was eligible for enrollment in this study. Eligible participants were deemed to be appropriate surgical candidates for BR during their preoperative patient evaluation. Written consent for this study and preoperative nasal swabs were obtained at patients' preoperative clinic visit approximately one to four weeks prior to surgery. Postoperative nasal swabs were obtained within 1 to 4 months postoperatively during routine clinic appointment. As the nature of this study was only observational, patients found to be preoperatively colonized with MRSA were not treated. Patients postoperatively colonized with MRSA without evidence of wound or systemic infection were not treated. As is standard at our institution, all patients received 2 gm of cefazolin intravenously 30 minutes prior to skin incisions. Patients allergic to penicillin received clindamycin.
Data Collection
The primary outcome measures include: the total number or patients preoperatively positive for nasal MRSA, total number of patients postoperatively positive for MRSA, the incidence of postoperative conversion to nasal MRSA carrier state, and rate of postoperative complications based on carrier status. Documented surgical complications within 60 days of surgery include: urgent or emergent return to the OR, unanticipated patient readmission, breast or donor site seroma (as defined by clinically evident fluid collection requiring aspiration), hematoma requiring OR evacuation, infection treated with by mouth or intravenous (IV) antibiotics or OR wash-out, mastectomy skin flap or nipple necrosis requiring serial dressing changes or clinic/ OR debridement, symptomatic fat necrosis requiring debridement, implant exposure, implant failure, partial flap necrosis (requiring serial dressing changes or debridement), delayed wound healing (requiring serial dressing changes >3 weeks following surgery or debridement and closure) and total flap loss. Determination of an infection was made by a clinical exam by the senior surgeon. The management of postoperative infections was not altered based on participation in this study. Patients presenting with superficial infection (increased erythema, pain, tenderness, without systemic illness) were treated with oral antibiotics. Cefoxitin was routinely chosen regardless of colonization status. Patients that were penicillin allergic, received clindamycin. These patients were then followed closely for resolution of their symptoms. Infections only requiring oral antibiotics were documented as minor complications. Patients that presented with more substantial drainage, redness, and possible signs of systemic infection were admitted and treated with IV antibiotics or wash-out at the discretion of the operating surgeon. A major complication was defined as any complication requiring an unanticipated readmission or return to the operating room.
Patient demographic and clinical information was obtained through our institution's electronic medical record. The variables of interest include: age, body mass index (BMI), smoking status, type of procedure, comorbidities, stage of breast cancer, treatment with radiation and chemotherapy, and follow up.
Culture and Microbiological Methods

Samples
Nasal double swabs were collected from both anterior nares by inserting swab up to 2.5 cm from the edge of the nare and rolled 5 times. The swabs were then returned to their container containing BBL ™ Culture Swab Liquid
Amies. All swabs were refrigerated and transferred to the Emory University laboratory within 24 hours. The swabs were inoculated onto the Spectra (ThermoFisher Scientific, Waltham, MA) MRSA chromogenic plate and processed according to the manufactures specifications. Plates were placed in an incubator for 24 hours and read by lab technologists. MRSA colonies appeared denim blue. Only 1 colony was required for a positive sample.
Statistical Analysis
Rates of preoperative and postoperative carrier state were calculated. Conversion rate to colonization was calculated from the ratio of patients that were positive postoperatively but were not positive preoperatively. The clinical and demographic variables and complication rates of both the positive and negative groups at each time point were analyzed and compared using both the Fisher's exact and t test as appropriate. A P-value of .05 was considered significant. All statistical analysis was performed using IBM SPSS Statistics 23.0 (IBM Corp., Armonk, NY).
RESULTS
Patient Population
A total of 122 female patients had sufficient data to be included. The average age was 54.4 years (range, 27-81 years) ( Table 1 ). The average BMI was 29.6 kg/m 2 (range, 19.0-54.7 kg/m 2 ), and 40.2% (n = 49) of patients had a BMI >30. The majority of patients had skin-sparing mastectomy (n = 58, 47.5%) and immediate BR (n = 114, 93.4%) with implant or expanders (n = 51, 41.8%). Additionally, the majority (n = 68, 55.7%) of women received radiotherapy, and 41.0% (n = 50) received chemotherapy. Eighty-two (67.2%) patients had sentinel lymph node biopsy and the majority were stage 0 (n = 42, 34.4%) and stage I (n = 36, 29.5%) disease. The most common type of breast pathology was infiltrating ductal carcinoma (n = 60, 49.2%). Postoperatively, the average hospital length of stay was 1.6 days (range, 0-6 days).
Preoperative MRSA Colonization
The incidence of MRSA carriers preoperatively was 3.3% (n = 4). There was not a significant difference between clinical and demographic variables for patients between patients that were MRSA carries preoperatively those that were not (Table 2) . However, hospital length of stay tended to be longer in patients that were colonized preoperatively (2.8 days vs 1.6 days, P = .075).
Postoperative Colonization
Postoperatively, 5 patients (4.1%) were MRSA carriers. One patient was positive at both preoperative and postoperative time points for a conversion rate of 80.0% (4/5). Clinical and demographic variables between postoperative carriers and non-carriers were similar ( Table 3 ). The hospital length of stay tended to be longer in patients that were MRSA carriers postoperatively (2.8 days vs 1.8 days, P = .072). 
Complications and Colonization for Entire Cohort
There were a total of 40 complications for the entire cohort (32.8%) ( Table 4 ). The majority of complications were minor (n = 26), and the most common complication was a postoperative surgical site infection (n = 13, 10.7%) followed by delayed wound healing (n = 9, 7.4%). There was not a significant difference in the overall complication rate between carriers and non-carriers.
Preoperative Carriers
Patients that were preoperative MRSA carriers tended to have a higher incidence of major complications (25.0% vs 1.7%, P = .056) ( Table 5 ). There was not a significant difference in infections between the two groups (25.0% vs 10.2%, P = .367).
Postoperative Carriers
Postoperative colonization tended to be associated with an increased incidence of having a postoperative complication (80.0% vs 35.7%, P = .068) ( Table 6 ). Postoperatively colonization was significantly associated with a higher rate of delayed wound healing (40.0% vs 4.8%, P = .035). Additionally, the incidence of minor complications (60.0% vs 20.2%, P = .073) and implant exposure (20.0% vs 0.0%, P = .056) tended to be higher in the patients colonized postoperatively. 
DISCUSSION
The burden postoperative complications to post-mastectomy reconstruction patients can be significant, and it is exceedingly important to prevent their development. We have demonstrated that 3.3% of our reconstructive patients are MRSA carriers and this number is even higher postoperatively. Although MRSA colonization and postoperative conversion of BR patients in our study was relatively small (<5%), we showed an association between postoperative colonization and delayed wound healing (40.0% carriers vs 4.8% noncarriers, P = .035). This can be considered preliminary data and underscores the importance of larger, multi-institutional intention to treat studies. Previous reports have shown that MRSA is a common pathogen in chronic wounds 19 and colonization of MRSA increases the development of invasive MRSA infections. 20 While none of the patients in our study developed an invasive MRSA infection (ie, bacteremia, abscess), colonization may lead to wound contamination that subsequently impairs healing. The principles of wound healing are of central importance in plastic surgery with many uncontrollable patient risk factors, diabetes, age, radiation, stress, smoking, that are often cited as increasing the risk for wound complications. Given the majority of these factors are beyond the surgeon's control, the identification of a modifiable risk factor such as MRSA colonization creates the potential for preventing poor postoperative outcomes in our patients.
Compared to women who were not carriers, colonized patients at both time points tended to spend about one day longer in the hospital after surgery. In the current healthcare system, estimates of the cost for one day in the hospital is $4,300 (IFH); therefore, an additional day is a significant drain to our patients and the healthcare system globally. Given the observational nature of this study and our inability to perform multivariate analysis due to sample size, we cannot conclude that colonization resulted in longer hospital stays. However, we did find an association in this small sample size on univariate analysis. Based on these preliminary data, larger studies with multivariate analysis would need to be conducted to determine if a true association between colonization and increased hospital stay exists. Furthermore, if an association between nasal colonization and increased hospital length of stay exists, it is likely dependent on the time of colonization: preoperative vs postoperative. Patients that were postoperatively colonized may have been in the hospital longer for other unforeseen factors that resulted in becoming a carrier as longer hospital stays are associated with converting to MRSA carrier status. 21 In the preoperatively colonized patients, previous reports have shown diabetes, immunosuppression, exposure to the healthcare system as a whole, prior antibiotic therapy, 15, 22, 23 older age, 14, 24 and having a malignancy 14 as independent risk factors for being nasal MRSA carriers. While the clinical and demographic variables of the colonized and non-colonized patients were similar in our study, there may be some other confounder we were not able to account for in this analysis.
The majority of women in our study had breast cancer. When combined with the repeated healthcare system exposure and consequent immunosuppression of undergoing chemotherapy and radiotherapy, these women were at even higher risk of becoming colonized. Additionally, colonization may also represent a marker for other factors such as older age, recent illness requiring antibiotics, diabetes, immunosuppression, or healthcare system exposure (ie, chemotherapy or radiotherapy) that also put our patients at risk for wound complications and infections, so our results may not represent a true cause and effect relationship. Given the small number of patients colonized in our study, we were not able to perform multivariate analysis to elucidate these potential associations in the BR patient.
Though commonly Staphylococcus epidermidis, the majority of organisms cultured from SSIs following BR have been shown to be various species of staphylococcus skin flora.
25-33 While we did not find an association between postoperative infections and MRSA colonization at either time point, our analysis revealed that implant exposure tended to be higher in women that were postoperatively colonized (20.0% vs 0.0%, P = .056). If this association is confirmed with larger studies, this may have important implications for implant loss if recognized on screening and treated appropriately. Previous reports have linked subclinical infection with these species to biofilm formation and increased risk for capsular contracture following implant-based reconstruction. 31, 33 Crucially, when infection is caused by MRSA, patients are more likely to fail operative implant salvage 29 making clinical infections of MRSA a significant burden to the BR patient. Our short term analysis did not show a significant difference between postoperative colonization and implant failure (20.0% vs 4.8%, P = .256), but 60 days is likely not enough follow-up time to detect the true incidence of this complication. Additionally, women colonized may also be are at a higher risk of developing capsular contracture in the future.
Although the CDC does not recommend routine screening for MRSA colonization in all patients, 34 screening surgical patients, particularly those receiving implantable devices, may reduce the increased risk for morbidity following postoperative infection. 12 Given the trend toward increased implant exposure in patients that are colonized, it is possible screening and treating preoperatively prior to implant or tissue expander placement may reduce their risk of implant loss. In a previous large, multicenter, randomized control intention to treat analysis by Bode et al, 6771 surgical patients were screened and carriers treated with 5 day course of mupirocin-chlorhexidine. The resultant analysis showed almost a 50% reduction in MRSA infections (3.4% vs 7.7%) with this program. Additionally, the length of hospital stay was significantly shorter in the patients that were treated compared to those that were not. The authors concluded that 250 patients would need to be screened and 23 treated in order to prevent 1 hospital MRSA infection. In another report of 963 patients undergoing Moh's surgery, preoperative screening of MRSA and decontamination showed a significant reduction in postoperative MRSA infections. In this report, 22 carriers underwent decontamination with 5 to 7 days of trimethoprim-sulfamethoxazole. The incidence of nasal MRSA carriage in this study was 2.4% similar to our patient population. 17 Although our infection rate was low (10.7%) and we did not have any invasive MRSA Infections, this is likely a result of the small number of patients screened. In the above reports, the incidence of MRSA colonization was also very low (<3.0%), so even with relatively small numbers of colonized patients a large scale screening and treatment program can substantially change the incidence of postoperative complications. Although the goal here was to obtain preliminary data, the major limitation of this study is the relatively small number of patient's that were colonized at both the preoperative and postoperative time points. This limited our ability to perform multivariate analysis and to detect a true association if one were to exist and control for confounding variables in this patients. Furthermore, the above analysis is from a single center and is therefore not necessarily generalizable to other patient populations. Additionally, of the four patients that were positive preoperatively, three were negative after surgery possible indicating that preoperative screening may be unnecessary and not reflect patients' carrier status or outcome postoperatively. Nevertheless, the strengths of this study are its design and that it is the first study of its kind looking into the rates of MRSA colonization in BR patients and the effect of colonization on postoperative BR outcomes. All of our groups were similar in both demographic and clinical variables likely limiting any known factors that may have influenced the resultant analysis. Additionally, the prospective design gives us the ability to calculate the true incidence of MRSA colonization. All the study participants had surgery at the same institution, by the same surgeon, and were seen in a single office for follow up, thereby limiting many external environmental factors that may increase the risk of becoming an MRSA carrier.
CONCLUSION
The MRSA colonization rate of routine BR patients is low (<5.0%); however, in our analysis postoperative delayed wound healing postoperatively was associated with MRSA carrier state. While the overall complication rate was not significantly associated with being a carrier, there tended to be an increased risk of complications in those patients colonized postoperatively. Given the high stakes of breast reconstruction, especially in the expander or implant technique, controlling this risk factor may have important implications for decreasing complications and improving outcomes. A large multicenter intention to treat analysis would be beneficial in determining if treating these carriers is of value to our patients.
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